OraSure Technologies, Inc. (NASDAQ:OSUR)

CAPS Rating: 2 out of 5

The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.

Recs

1
Player Avatar biovestor (< 20) Submitted: 6/28/2008 7:02:41 AM : Outperform Start Price: $3.94 OSUR Score: +156.65

Beaten down recently on concerns over its HIV test and legal issues, but still has excellent prospects for its over-the-counter oral fluid HIV test and its hepatitis C test for healthcare professionals.

Featured Broker Partners


Advertisement